TOFIDENCE™® Tocilizumab（400mg/20mL）

Please take it under the guidance of experienced pharmacist.

TOFIDENCE(tocilizumab-bavi), is a treatment developed as a biosimilar to the reference product ACTEMRA. TOFIDENCE is indicated for the treatment of moderately toseverely active rheumatoid arthritis, polyarticular juvenile idiopathicarthritis and systemic juvenile idiopathic arthritis in the US and EU.

Prescribing Information TOFIDENCE™®

Indications

Rheumatoid Arthritis (RA)

Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.

Systemic Juvenile Idiopathic Arthritis (SJIA)

Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.